Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
Department of Medicine, National Cheng Kung University Medical College, Tainan, Taiwan; Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Executive Yuan, Tainan, Taiwan.
J Microbiol Immunol Infect. 2018 Apr;51(2):243-250. doi: 10.1016/j.jmii.2016.08.013. Epub 2016 Dec 18.
Clostridium difficile infection (CDI) is well-known as the major cause of infectious diarrhea in hospitalized patients. Community-onset CDI (CO-CDI) is an emerging threat. However, clinical information of CO-CDI in Taiwan remains scarce.
A retrospective study was conducted at a medical center in southern Taiwan. Symptomatic patients between 2007 and 2015 with C. difficile toxin or tcdB detected in stool were identified as CDI, and were classified as CO-CDI [including community-associated CDI (CA-CDI) and community-onset health care facility-associated CDI (CO-HCFA-CDI)] and health care facility-onset CDI (HCFO-CDI).
Of 427 patients, 15 (3.5%) were CA-CDI, 49 (11.5%) CO-HCFA-CDI, and 363 (85.0%) HCFO-CDI. Despite major involvement of the elderly (mean age: 66.1 years vs. 69.9 years, p = 0.46), no significant differences were noted between CA-CDI and CO-HCFA-CDI groups, except that solid organ cancer was more common in the CO-HCFA-CDI group. The CO-CDI group more often presented with abdominal pain but had shorter hospital stays and less exposure of proton-pump inhibitors or broad-spectrum antibiotics than the HCFO-CDI group did. The mortality rate related to CDI was 4.7% (3 patients) in the CO-CDI group. Despite a lower in-hospital mortality rate in the CO-CDI group (10.9% vs. 22.0%; p = 0.04), the recurrence rate was similar (10.9% vs. 7.2%; p = 0.3).
CO-CDI is not common but associated with substantial morbidity and mortality. Physicians should put CDI into consideration among patients who present community-onset fever, diarrhea, or abdominal pain alone or in combination.
艰难梭菌感染(CDI)是住院患者感染性腹泻的主要病因。社区获得性 CDI(CO-CDI)是一种新出现的威胁。然而,台湾 CO-CDI 的临床信息仍然很少。
在台湾南部的一家医疗中心进行了一项回顾性研究。2007 年至 2015 年间,在粪便中检测到艰难梭菌毒素或 tcdB 的症状性患者被确定为 CDI,并分为 CO-CDI[包括社区相关性 CDI(CA-CDI)和社区获得性医疗机构相关 CDI(CO-HCFA-CDI)]和医疗机构相关性 CDI(HCFO-CDI)。
在 427 名患者中,15 名(3.5%)为 CA-CDI,49 名(11.5%)为 CO-HCFA-CDI,363 名(85.0%)为 HCFO-CDI。尽管老年人占很大比例(平均年龄:66.1 岁与 69.9 岁,p=0.46),但 CA-CDI 和 CO-HCFA-CDI 组之间无显著差异,除了实体器官癌在 CO-HCFA-CDI 组更为常见。CO-CDI 组更常出现腹痛,但住院时间更短,质子泵抑制剂或广谱抗生素暴露的情况少于 HCFO-CDI 组。CO-CDI 组与 CDI 相关的死亡率为 4.7%(3 例)。尽管 CO-CDI 组的院内死亡率较低(10.9%与 22.0%;p=0.04),但复发率相似(10.9%与 7.2%;p=0.3)。
CO-CDI 并不常见,但与较高的发病率和死亡率相关。医生应在出现社区获得性发热、腹泻或腹痛的患者中考虑 CDI,无论单独出现还是联合出现。